Le Lézard
Classified in: Health
Subjects: POLITICS, HEALTH

Canadian Centre on Substance Use and Addiction Looks Forward to Federal Cannabis Act Review


OTTAWA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- The Canadian Centre on Substance Use and Addiction (CCSA) welcomes the planned federal cannabis review and looks forward to opportunities to contribute evidence on public health, public safety and equity. This evidence is based on research by our experts and with communities in keeping with CCSA's legislated role to provide neutral, data-driven, third-party advice to help governments, organizations and individuals make informed decisions on issues of substance use and addiction.

"We feel the review provides an important opportunity to ensure Canada is achieving the public health and safety objectives it set when legalizing cannabis. It will also help the public understand what has been learned and researched," says CEO Dr. Alexander Caudarella.

On-Premise Cannabis Use: Public Health and Safety Considerations and Cannabis Legalization: 2021-2022 Observations are the latest in CCSA's suite of cannabis resources. Others include a Is It OK to Use Cannabis Use During Pregnancy and Breastfeeding public awareness poster and a Knowing Your Limits with Cannabis: A Practical Guide to Assessing Cannabis Use booklet, both of which focus on harm reduction techniques.

MEDIA CONTACT
Christine LeBlanc, Communications Advisor
Email: [email protected]
Tel.: 613-898-6343



These press releases may also interest you

at 12:46
Melmark, a nationally-recognized non-profit human services provider recently held its biennial fundraising gala, The Dream Maker's Ball: Melmark Generations. Over 200 guests gathered at the Crystal Tea Room in Philadelphia on Saturday, April 20th to...

at 12:25
The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology...

at 12:20
Johnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment with ERLEADA® (apalutamide) and androgen deprivation therapy (ADT) in patients with HRLPC who have undergone...

at 12:15
According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further alarm is being spread by the United Nations, whose health authorities are predicting global cancer...

at 12:12
Hoag announced today at its annual Nurse of the Year celebration a $15 million gift from philanthropists Julia and George Argyros that will further enhance Hoag's nationally renowned nursing services and support the Julia Argyros Center for Nursing...

at 12:00
The European Wound Management Association (EWMA) presented Fertram Sigurjonsson, founder and CEO of the medical-fish-skin company Kerecis, with the President's Wound Care Entrepreneur of the Year Award. The award was announced at the annual EWMA...



News published on and distributed by: